日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

The Banff 2017 Kidney Meeting Report: Revised diagnostic criteria for chronic active T cell-mediated rejection, antibody-mediated rejection, and prospects for integrative endpoints for next-generation clinical trials

2017年班夫肾脏病会议报告:慢性活动性T细胞介导排斥反应、抗体介导排斥反应的修订诊断标准,以及下一代临床试验综合终点的展望

Haas, M; Loupy, A; Lefaucheur, C; Roufosse, C; Glotz, D; Seron, D; Nankivell, B J; Halloran, P F; Colvin, R B; Akalin, Enver; Alachkar, N; Bagnasco, S; Bouatou, Y; Becker, J U; Cornell, L D; Duong van Huyen, J P; Gibson, I W; Kraus, Edward S; Mannon, R B; Naesens, M; Nickeleit, V; Nickerson, P; Segev, D L; Singh, H K; Stegall, M; Randhawa, P; Racusen, L; Solez, K; Mengel, M

Interferon Gamma ELISPOT Testing as a Risk-Stratifying Biomarker for Kidney Transplant Injury: Results From the CTOT-01 Multicenter Study

干扰素γ ELISPOT检测作为肾移植损伤风险分层生物标志物:来自CTOT-01多中心研究的结果

Hricik, D E; Augustine, J; Nickerson, P; Formica, R N; Poggio, E D; Rush, D; Newell, K A; Goebel, J; Gibson, I W; Fairchild, R L; Spain, K; Iklé, D; Bridges, N D; Heeger, P S

cPRA Increases With DQA, DPA, and DPB Unacceptable Antigens in the Canadian cPRA Calculator

cPRA 值随 DQA、DPA 和 DPB 抗原的增加而升高,这些抗原在加拿大 cPRA 计算器中属于不可接受的抗原。

Tinckam, K J; Liwski, R; Pochinco, D; Mousseau, M; Grattan, A; Nickerson, P; Campbell, P

Comprehensive assessment and standardization of solid phase multiplex-bead arrays for the detection of antibodies to HLA

对用于检测HLA抗体的固相多重微珠阵列进行全面评估和标准化

Reed, E F; Rao, P; Zhang, Z; Gebel, H; Bray, R A; Guleria, I; Lunz, J; Mohanakumar, T; Nickerson, P; Tambur, A R; Zeevi, A; Heeger, P S; Gjertson, D

Comprehensive assessment and standardization of solid phase multiplex-bead arrays for the detection of antibodies to HLA-drilling down on key sources of variation

对用于检测HLA抗体的固相多重微珠阵列进行全面评估和标准化——深入探究变异的关键来源

Reed, E F; Rao, P; Zhang, Z; Gebel, H; Bray, R A; Guleria, I; Lunz, J; Mohanakumar, T; Nickerson, P; Tambur, A R; Zeevi, A; Heeger, P S; Gjertson, D

Multicenter validation of urinary CXCL9 as a risk-stratifying biomarker for kidney transplant injury.

多中心验证尿液 CXCL9 作为肾移植损伤风险分层生物标志物

Hricik D E, Nickerson P, Formica R N, Poggio E D, Rush D, Newell K A, Goebel J, Gibson I W, Fairchild R L, Riggs M, Spain K, Ikle D, Bridges N D, Heeger P S